Allianz Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-16,270
| Closed | -$803K | – | 2057 |
|
|
2017
Q2 | $803K | Sell |
16,270
-29,672
| -65% | -$1.46M | ﹤0.01% | 1750 |
|
|
2017
Q1 | $2M | Buy |
45,942
+7,825
| +21% | +$340K | ﹤0.01% | 1504 |
|
|
2016
Q4 | $1.87M | Buy |
38,117
+2,489
| +7% | +$122K | ﹤0.01% | 1499 |
|
|
2016
Q3 | $1.71M | Buy |
+35,628
| New | +$1.71M | ﹤0.01% | 1541 |
|
|
2015
Q2 | – | Sell |
-285,408
| Closed | -$11.8M | – | 1879 |
|
|
2015
Q1 | $11.8M | Sell |
285,408
-85,963
| -23% | -$3.54M | 0.01% | 765 |
|
|
2014
Q4 | $15.1M | Sell |
371,371
-15,758
| -4% | -$642K | 0.02% | 696 |
|
|
2014
Q3 | $14.2M | Buy |
387,129
+4,588
| +1% | +$168K | 0.02% | 684 |
|
|
2014
Q2 | $17.7M | Sell |
382,541
-38,944
| -9% | -$1.8M | 0.02% | 586 |
|
|
2014
Q1 | $17.3M | Buy |
421,485
+115,624
| +38% | +$4.75M | 0.02% | 582 |
|
|
2013
Q4 | $11.7M | Buy |
305,861
+23,814
| +8% | +$909K | 0.01% | 671 |
|
|
2013
Q3 | $6.76M | Buy |
282,047
+31,747
| +13% | +$761K | 0.01% | 808 |
|
|
2013
Q2 | $4.26M | Buy |
+250,300
| New | +$4.26M | 0.01% | 933 |
|